Reporting owner · CIK 0001645617

Schlackman Scott

SEC Form 4 history across 1 companies, 2 transactions and 1 filings.

DIRMEDIFAST INC
Open-market transaction mix100% buys2 buys · 0 sales

Available history · May 08, 2026 – May 11, 2026

Filings1Form 4 records
Buying$63K2 purchases
Selling$00 sales
Net value$63KBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Schlackman Scott transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
MEDMEDIFAST INC
Schlackman ScottDIRP · buySEC filing ↗$31.3kView disclosure →
MEDMEDIFAST INC
Schlackman ScottDIRP · buySEC filing ↗$31.6kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

buy at MEDIFAST INC on May 11, 2026 valued at $31,325.

Review SEC filing
Latest sale

No open-market insider sale is available.

Monthly open-market activity

Last 1 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
May 202620$62,950.00$0.00$62,950.00

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$31.5K
Median P/S size$31.5K
Direct2
Indirect0
May 11, 2026buy

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return+10.8%Across 2 open-market buys
Median return+10.8%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Scope is the available history shown in this profile.
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

2 observations · May 8, 2026 – May 11, 2026. Window ends at the latest available report, not today.

Selected observation · May 11, 202630548.707000 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
May 8, 202628048.707000May 12, 2026View transaction
May 11, 202630548.707000May 12, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Schlackman Scott Insider Activity FAQ

SEC Form 4 context

Who is Schlackman Scott?

Schlackman Scott is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001645617.

Which companies has Schlackman Scott reported transactions for?

MEDIFAST INC

When was Schlackman Scott's latest insider buy?

buy at MEDIFAST INC on May 11, 2026 valued at $31,325.

When was Schlackman Scott's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.